Search Results
Role of HER2 expression and pCR in predicting early outcomes in HER2-positive breast cancer
Independent validation of the HER2DX genomic test in HER2-positive breast cancer
Her-2 Amplification Assessment in Breast Cancer FFPE Samples: QuantStudio 3D Digital PCR vs. ISH
#ESMO21 Expert Video Report on HER2-positive early breast cancer
New Perspectives on the Full Spectrum of HER2 Expression in Breast Cancer
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
Optimizing adjuvant treatment in HR+/HER2- early breast cancer
HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches
Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg
Impact of biomarkers on pCR and survival after T-DM1 with or without ET vs trastuzumab and ET in...
